The role of H. Pylori infection in the pathophysiology of duodenal ulcer disease

Journal of Physiology and Pharmacology

Volumn 48, Issue 3, 1997, Pages 287-295

  McColl, K E L ^a   El Omar, E M ^a   Gillen, D ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Cholecystokinin; Gastrin; Gastrin releasing peptide; Ulcer disease Gastritis

Indexed keywords

GASTRIN;

ACID SECRETION; BACTERIAL INFECTION; DUODENUM ULCER; GASTRITIS; HELICOBACTER PYLORI; HUMAN; METAPLASIA; PATHOPHYSIOLOGY; REVIEW; STOMACH ACID SECRETION; STOMACH GLAND; STOMACH MUCOSA;

DUODENAL ULCER; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PYLORIC ANTRUM;

EID: 0030763866     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Dixon MM. IV Helicobacter pylori and peptic ulceration: Histopathological aspects. J Gastroenterol Hepatol 1991; 6: 125-130.
2. McColl KEL, Fullarton GM, Chittajallu R et al. Plasma gastrin, daytime intragastric pH, and noctural acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 3, 339-346.
3. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1989; 1167-1168.
4. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. Gastroenterology 1991; 100: 1571-1575.
5. Smith JTL, Pounder RE, Nwokolo CU et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori Gut 1990; 31: 522-525.
6. Mulholland G, Ardill JES, Fillmore D, Chittajallu RS, Fullarton GM, McColl KEL. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in Gastrin-17. Gut 1993; 34: 757-761.
7. Chittajallu RS, Dorrian CA, Neithercut WD, Dahill S, McColl KEL. Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut 1991; 32: 1286-1290.
8. Graham DY, Go MF, Lew GM, Genta RM, Rehfeld JF. Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol 1993; 28: 690-694.
9. Walsh JH, Richardson CT, Fordtran JS. PH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462-468.
10. Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. Digestion 1990; 45: 1-8.
11. Kleibeuker JH, Eysselein VE, Maxwell VE, Walsh JH. Role of endogenous secretin in acid-induced inhibition of human gastric function. J Clin Invest 1984; 73: 526-532.
12. Kent KC, Raybould HE, Walsh JH. Cholecystokinin inhibits gastric acid secretion through type "A" Cholecystokinin receptors and somatostatin in rats. Am J Physiol 1992; 26: G287-G292.
13. Schmidt WE, Schenk S, Nustede R, Holst JJ, Folsch UR, Creutzfeld W. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 1994; 107: 1610-1620.
14. Buchan AMJ, Meloche RM, Kwok YN, Kofod H. Effect of cholecystokinin and secretion on somatostatin release from cultured antral cells. Gastroenterology 1993; 104: 1414-1419.
15. Seal AM, Meloche RM, Liu YQE, Buchan AMJ, Brown JC. Effect of monoclonal antibodies to somatostatin on somatostatin-induced and intestinal fat-induced inhibition of gastric acid secretion in the rat. Gastroenterology 1987; 92: 1187-1192.
16. Holst JJ, Orskov C, Seier-Poulsen S. Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion. Digestion 1992; 51: 95-102.
17. Kaneko H, Nakada K, Mitsuma T et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992; 37: No. 3: 409-416.
18. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.
19. Odum D, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 1994; 35: 615-618.
20. Queiroz DMM, Mendes EN, Rocha GA et al. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993; 28: 858-864.
21. Queiroz DMM, Moura SB, Mendes EN, Rocha GA, Barbos AJA. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet 1994; 343: 1191-1194.
22. Sumii M, Summi K, Tari A et al. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol 1994; 89: No. 9: 1515-1519.
23. Tarnasky PR, Kovacs TOG, Sytnik B, Walsh JH. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993; 38: No. 9: 1681-1687.
24. Konturek JW, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroenterol 1995; 30: 738-744.
25. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-487.
26. Chittajallu RS, Neithercut WD, Macdonald AMI, McColl KEL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations. Gut 1991; 32: 21-24.
27. Nujumi AMEI, Dorrian CA, Chittajallu RS, Neithercut WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic. acid on serum gastrin in duodenal ulcer subjects. Gut 1991; 32: 866-870.
28. Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats. Gastroenterology 1987; 92: 406-413.
29. Harris PR, Mobley HLT, Perez-Perez GU, Blaser MJ, Smith PD. Helicobater pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996; 111: 419-425.
30. Beales ILP, Calam J. Helicobacter pylori infection and exogenous tumour necrosis factor alpha (TNFα) produce similar effects on gastrin release from human sntral fragments. Gut 1996; 38: (suppl.), A12.
31. Courillon-Mallet A, Launay J-M, Roucayrol A-M et al. Helicobacter pylori infection: physiopathologic implication of Nα-Methyl histamine. Gastroenterology 1995; 108: 959-966.
32. McColl KEL, El-Omar E, Gillen D, Ardill JES, Murray L, Crabtree JE. H. pylori-induced hypergastrinaemia is related to bacterial CagA status. Gastroenterology (in press).
33. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060-1065.
34. El-Omar E, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterologv 1995; 109: 681-691.
35. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobater pylori. Gut 1993; 34: 888-892.
36. Harris AW, Gummett PA, Misiewicz JJ, Bron JH. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid output to gastrin releasing peptide and pentagastrin. Gut 1996; 38: 663-667.
37. Gillen DG, El-Omar E, Wirz A, Ardill JES, McColl KEL. Regulation of corpus mucosal function in H. pylori infected DU patients versus healthy volunteers. Gastroenterology (in press).
38. Dixon MF. IV Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol & Hepatol 1991; 6: 125-130.
39. Dixon MF. Acid, ulcers and H. pylori. Lancet 1993; 342: 384-385.
40. Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997; 112: 707-717.
41. Khulusi B, Badve S, Patel P et al. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 1996; 110: 452-458.
42. Hogan DL, Rapier RC, Drellinger A et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110: 705-716.